Vaccines. Searching for a parasite's weak spot.
Using a host of new technologies, vaccine developers are trying to target the malaria parasite at every stage of its complex life cycle. Researchers now predict that within 5 or 10 years they will have a successful vaccine that will actually save lives. But in malaria vaccine research, the concept of "success" comes with caveats.
Taubes
G
G
D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000096:biosynthesis / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology; D002675:Child, Preschool; D009033:Culicidae / Q000469:parasitology; D004912:Erythrocytes / Q000469:parasitology; D006801:Humans; D008099:Liver / Q000469:parasitology; D008288:Malaria / Q000469:parasitology / Q000517:prevention & control* / Q000635:transmission; D017780:Malaria Vaccines / Q000276:immunology; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology*; D015800:Protozoan Proteins / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019444:Vaccines, DNA / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D017780:Malaria Vaccines; D015800:Protozoan Proteins; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; C041595:circumsporozoite protein, Protozoan